Referenser och regelverk

1. Acosta S, Frykholm P, Granath A, Hammarskjöld F, Lindgren S, Lindwall R, Pikwer A, Sandström K, Taxbro K, Åkeson J. Riktlinjer för central venkateterisering. Svensk förening för anestesi och intensivvård (SFAI); 2018.
2. Infektioner vid centrala venösa infarter : åtgärder för att förebygga. Stockholm: Sveriges Kommuner och Regioner (SKR); 2011.
3. Tanner J, Moncaster K, Woodings D. Preoperative hair removal: a systematic review. J Perioper Pract. 2007;17(3):118-21, 24-32.
4. Langgartner J, Linde HJ, Lehn N, Reng M, Scholmerich J, Gluck T. Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters. Intensive Care Med. 2004;30(6):1081-8.
5. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e:162-63.
6. Guiffant G, Durussel JJ, Flaud P, Vigier JP, Merckx J. Flushing ports of totally implantable venous access devices, and impact of the Huber point needle bevel orientation: experimental tests and numerical computation. J Adv Nurs. 2009;65:2007-2021.
7. Mitchell MD, Anderson BJ, Williams K, Umscheid CA. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. J Adv Nurs. 2009;65:2007-2021.
8. Spolning av CVK och subkutan venport med heparin eller enbart NaCl. Skånes universitetssjukhus. Enheten för HTA; 2013:01.
9. Goossens GA, Jérôme M, Janssens C, Peetermans WE, Fieuws S, Moons P, Verschakelen J, Peerlinck K, Jacquemin M, Stas M. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Ann Oncol. 2013;24(7):1892-9.
10. Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med. 2004;140(1):18-25.
11. Pronovost P. Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project. Am J Infect Control. 2008;36(10):S171 e 1-5.
12. Warren DK, Yokoe DS, Climo MW, Herwaldt LA, Noskin GA, Zuccotti G, et al. Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the prevention epicenter program. Infect Control Hosp Epidemiol. 2006;27(1):8-13.

Övriga referenser

• Att förebygga vårdrelaterade infektioner: ett kunskapsunderlag. Stockholm: Socialstyrelsen; 2006.
• Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.
• Mimoz O, Villeminey S, Ragot S, Dahyot-Fizelier C, Laksiri L, Petitpas F, et al. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care. Arch Intern Med. 2007;167(19):2066-72.
• Safdar N, Fine JP, Maki DG. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med. 2005;142(6):451-66.

Regelverk

• SFS 2008:355 Patientdatalag. Stockholm: Socialdepartementet
• SOSFS 2011:9. Ledningssystem för systematiskt kvalitetsarbete. Stockholm: Socialstyrelsen